Neurologi & Neuropsykiatri

HV banner
20 oktober 2022 9:30 - 21 oktober 2022 16:15
Save Appointment
Vidareutbildning för huvudvärksintresserade specialister. Fokus på komplicerade patientfall.

Svenska Huvudvärkssällskapet tillsammans med Novartis har nöjet att bjuda in till en Lipuscertifierad tvådagarsutbildning om huvudvärk. Huvudvärk är en folksjukdom och en betydande diagnos, men hur tar...Läs mer

SE2204215898

Headache experts from across the Nordics met physically and online on the last day of spring to take stock of more than 3 years of clinical experience with CGRP monoclonal antibodies for migraine prevention. Topics included difficult-to-treat patients and hormonal influences in migraine.

With themes like: long-term efficacy and safety of CGRP mAbs, migraine’s impact on work life,...Läs mer

SE2206286378 (28 juni 2022)

Watch a recorded webinar where Dr Russell Ouellette tells us more about MRI use in MS, what is possible to detect and what should we look for? The webinar is approximately 60 minutes long and includes a Q&A section. The presentation is given in English.Läs mer

SE2203303340 (30 mars 2022)
Treating to target in MS: Treating to Target in MS: Why, How and When 1

Watch our expert panel discussion from the Novartis symposium at ECTRIMS 2021.

Are we using the right treatment at the right time?

In MS, acute lesions may evolve into active smoldering lesions over time, rendering an aggressive disease state. 2 Real-world findings indicate that high-...Läs mer

SE2204279261 (27 april 2022)

Migraine constitutes a significant burden, not only to the individual suffering from this disabling disease but also to the society via sick leaves and use of health care resources. Two recent registry studies outline the burden of migraine in a Nordic setting and highlight the potential of erenumab, the first monoclonal antibody 1 developed for prevention of migraine, to...Läs mer

SE2202284230 (28 februari 2022)
×

Ask Speakers

×

Medical Information Request